Scholars Central

EditorialPublished 30 Nov 2024

Dendritic Cells as Key Regulators in the Tumor Microenvironment: Implications for Immunotherapy

Authors: Miami Chemung

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Centre, USA

Immunology: Current Research

Volume 8 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dendritic cells (DCs) are crucial components of the immune system, playing an essential role in regulating immune responses, including those against tumors. In the tumor microenvironment (TME), DCs act as both tumor suppressors and facilitators of tumor progression, depending on their activation state and interaction with other immune cells. This duality reflects their complex role in either promoting antitumor immunity or contributing to immune evasion. DCs initiate immune responses by presenting antigens to T cells, but in tumors, they often become tolerogenic, supporting tumor survival. Strategies to modulate DC function within the TME have emerged as promising avenues for cancer immunotherapy. This review explores the role of DCs in the TME, their mechanisms of immune modulation, and how therapeutic strategies aimed at restoring DC function may improve the efficacy of immunotherapies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunology: Current Research
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Miami Chemung”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels